Trial intelligence / Profile preview

Effect of two dosing regimens of acetaminophen on the anticoagulant effect of warfarin

2006-006416-30Phase 4Active

Sponsor
Unité de Recherches Thérapeutiques
Start
Dec 2006
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of acetaminophen in Arterial Embolism And Arterial Thrombosis, venous thromboembolism (VTE), Atrial fibrillation (AFib) and 1 more, sponsored by Unité de Recherches Thérapeutiques. Primary endpoints: INR increase of at least 0.5 units with acetaminophen 2 g/day and Time to significant INR increase. Started Dec 2006; status: active.

02

Drugs

acetaminophen
03

Conditions

Arterial Embolism And Arterial Thrombosisvenous thromboembolism (VTE)Atrial fibrillation (AFib)thromboembolism

Beyond the preview

Go deeper on 2006-006416-30.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2006-006416-30.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call